Brief: A1M Pharma files patent application

Disruptive Pharma AB (publ)

07/11/2017 07:33

Nov 7 (Reuters) - A1M PHARMA AB  A1M.ST : 
    * PRECLINICAL STUDIES SHOWS A PROTECTIVE EFFECT OF 
CANDIDATE DRUG 
ROSGARD ON BONE MARROW 
    * FILED A PATENT APPLICATION 
    * WILL INCLUDE BIOMARKERS FOR BONE MARROW PROTECTION IN 
COMPANY'S 
SCHEDULED CLINICAL PROGRAM FOR ROSGARD 
    * AIMS TO INITIATE CLINICAL STUDIES FOR KIDNEY PROTECTION IN 
CONNECTION WITH RADIATION THERAPY DURING Q1 2018 
 
Source text for Eikon:  ID:nBQN2xcfdF  
Further company coverage:  A1M.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))